Literature DB >> 9790467

Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms.

T Tolessa1, M Gutniak, J J Holst, S Efendic, P M Hellström.   

Abstract

This study investigated effects of glucagon-like peptide-1(7-36)amide (GLP-1) on gastric emptying, small intestinal transit, and contractility of smooth muscle strips in rats. GLP-1 at doses of 10 and 20 pmol/kg/min administered intravenously dose-dependently retarded transit of the small intestine (P < 0.001), while only the higher dose of 20 pmol/kg/min retarded gastric emptying (P < 0.01). GLP-1 at concentrations up to 10(-4) M did not affect the basal tone or contractility of the gastrointestinal muscle strips that were stimulated with electric field stimulation or acetylcholine. Our results demonstrate that small intestinal transit seems more sensitive than gastric emptying to inhibition by GLP-1 at physiologic levels in plasma. Furthermore, this inhibition appears to be mediated through central mechanisms rather than through peripheral actions. Thus, GLP-1 is suggested to inhibit gastric emptying and small intestinal transit through an indirect effect via central or enteric nervous mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790467     DOI: 10.1023/a:1026678925120

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

Review 1.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

2.  A METHODOLOGICAL STUDY OF THE ENZYMATIC DETERMINATION OF GLUCOSE IN BLOOD.

Authors:  M HJELM; C H DE VERDIERCH
Journal:  Scand J Clin Lab Invest       Date:  1963       Impact factor: 1.713

3.  Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.

Authors:  S Mojsov; G C Weir; J F Habener
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut.

Authors:  J J Holst; C Orskov; O V Nielsen; T W Schwartz
Journal:  FEBS Lett       Date:  1987-01-26       Impact factor: 4.124

5.  Effect of glucagon-like peptide-1 on insulin secretion.

Authors:  K Shima; M Hirota; C Ohboshi
Journal:  Regul Pept       Date:  1988-08

6.  Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.

Authors:  C Orskov; J J Holst; S Knuhtsen; F G Baldissera; S S Poulsen; O V Nielsen
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

7.  Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans.

Authors:  R J Rushakoff; I D Goldfine; J D Carter; R A Liddle
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

8.  Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.

Authors:  M B Wheeler; M Lu; J S Dillon; X H Leng; C Chen; A E Boyd
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

9.  Impaired response of pancreatic polypeptide to hypoglycaemia: an early sign of autonomic neuropathy in diabetics.

Authors:  T Krarup; T W Schwartz; J Hilsted; S Madsbad; O Verlaege; L Sestoft
Journal:  Br Med J       Date:  1979-12-15

10.  Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.

Authors:  A Wettergren; H Petersen; C Orskov; J Christiansen; S P Sheikh; J J Holst
Journal:  Scand J Gastroenterol       Date:  1994-06       Impact factor: 2.423

View more
  31 in total

Review 1.  Small bowel review: normal physiology part 2.

Authors:  A B Thomson; M Keelan; A Thiesen; M T Clandinin; M Ropeleski; G E Wild
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

2.  Diabetes-related alterations in the enteric nervous system and its microenvironment.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Diabetes       Date:  2012-05-15

3.  GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats.

Authors:  Ajaykumar N Sharma; Sagar S Ligade; Jay N Sharma; Praveen Shukla; Khalid M Elased; James B Lucot
Journal:  Metab Brain Dis       Date:  2014-07-15       Impact factor: 3.584

4.  Abdominal surgery inhibits circulating acyl ghrelin and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2.

Authors:  Andreas Stengel; Miriam Goebel-Stengel; Lixin Wang; Almaas Shaikh; Nils W G Lambrecht; Jean Rivier; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

Review 5.  Classification and functions of enteroendocrine cells of the lower gastrointestinal tract.

Authors:  Ashok R Gunawardene; Bernard M Corfe; Carolyn A Staton
Journal:  Int J Exp Pathol       Date:  2011-04-25       Impact factor: 1.925

6.  Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats.

Authors:  Roger Reidelberger; Alvin Haver; Krista Anders; Bettye Apenteng
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-12       Impact factor: 4.310

7.  GLP-1R activation for the treatment of stroke: updating and future perspectives.

Authors:  Vladimer Darsalia; David Nathanson; Thomas Nyström; Thomas Klein; Åke Sjöholm; Cesare Patrone
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

Review 8.  Glucagon-like peptide 1 and appetite.

Authors:  Megan J Dailey; Timothy H Moran
Journal:  Trends Endocrinol Metab       Date:  2013-01-16       Impact factor: 12.015

9.  Long-term effects of lipase inhibition by orlistat on gastric emptying and orocecal transit time of a solid meal.

Authors:  Piotr Kocełak; Barbara Zahorska-Markiewicz; Krzysztof Jonderko; Magdalena Olszanecka-Glinianowicz; Agnieszka Zak-Gołab; Michał Holecki; Magdalena Kamińska; Małgorzata Szymszal
Journal:  J Gastroenterol       Date:  2008-08-17       Impact factor: 7.527

10.  Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.

Authors:  Elisabeth B Rüttimann; Myrtha Arnold; Jacquelien J Hillebrand; Nori Geary; Wolfgang Langhans
Journal:  Endocrinology       Date:  2008-10-23       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.